|
Volumn 17, Issue 1, 2000, Pages 47-54
|
Intratumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer patients treated with 5-FU-based chemotherapy.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
CISPLATIN;
DIHYDROPYRIMIDINE DEHYDROGENASE;
DRUG DERIVATIVE;
FLUOROURACIL;
OXIDOREDUCTASE;
THYMIDYLATE SYNTHASE;
TUMOR MARKER;
ADULT;
AGED;
ARTICLE;
CANCER STAGING;
ENZYMOLOGY;
FEMALE;
FOLLOW UP;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
MIDDLE AGED;
MORTALITY;
PATHOLOGY;
SURVIVAL RATE;
TIME;
ADULT;
AGED;
ANTIMETABOLITES, ANTINEOPLASTIC;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
DIHYDROURACIL DEHYDROGENASE (NADP);
FEMALE;
FLUOROURACIL;
FOLLOW-UP STUDIES;
HUMANS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
OXIDOREDUCTASES;
SURVIVAL RATE;
THYMIDYLATE SYNTHASE;
TIME FACTORS;
TUMOR MARKERS, BIOLOGICAL;
MLCS;
MLOWN;
|
EID: 0034223246
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.17.1.47 Document Type: Article |
Times cited : (92)
|
References (0)
|